S100A8 and myeloid sarcoma: S100A8/A9 concentrations are higher in the serum in multiple sclerosis (MS) patients [18] and in the cerebrospinal fluid (CSF) of Alzheimer’s disease (AD) patients [19] compared with healthy controls.